Q Wei1, Z Ye2, X Zhong3, L Li2, C Wang2, R E Myers2, J P Palazzo4, D Fortuna4, A Yan2, S A Waldman5, X Chen6, J A Posey2, A Basu-Mallick2, B H Jiang4, L Hou7, J Shu2, Y Sun8, J Xing9, B Li1, H Yang2. 1. Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville. 2. Department of Medical Oncology, Thomas Jefferson University, Philadelphia. 3. Department of Medicine, Vanderbilt University, Nashville. 4. Pathology, Anatomy and Cell Biology. 5. Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia. 6. Department of Public Health Sciences, University of Miami, Miami. 7. Department of Preventive Medicine, Northwestern University, Chicago, USA. 8. Department of Medical Oncology, Anhui Provincial Hospital, Hefei. 9. Department of Experimental Teaching Center of Basic Medicine, Fourth Military Medical University, Xi'an, China.
Abstract
BACKGROUND: Distant metastasis accounts for 90% of deaths from colorectal cancer (CRC). Genomic heterogeneity has been reported in various solid malignancies, but remains largely under-explored in metastatic CRC tumors, especially in primary to metastatic tumor evolution. PATIENTS AND METHODS: We conducted high-depth whole-exome sequencing in multiple regions of matched primary and metastatic CRC tumors. Using a total of 28 tumor, normal, and lymph node tissues, we analyzed inter- and intra-individual heterogeneity, inferred the tumor subclonal architectures, and depicted the subclonal evolutionary routes from primary to metastatic tumors. RESULTS: CRC has significant inter-individual but relatively limited intra-individual heterogeneity. Genomic landscapes were more similar within primary, metastatic, or lymph node tumors than across these types. Metastatic tumors exhibited less intratumor heterogeneity than primary tumors, indicating that single-region sequencing may be adequate to identify important metastasis mutations to guide treatment. Remarkably, all metastatic tumors inherited multiple genetically distinct subclones from primary tumors, supporting a possible polyclonal seeding mechanism for metastasis. Analysis of one patient with the trio samples of primary, metastatic, and lymph node tumors supported a mechanism of synchronous parallel dissemination from the primary to metastatic tumors that was not mediated through lymph nodes. CONCLUSIONS: In CRC, metastatic tumors have different but less heterogeneous genomic landscapes than primary tumors. It is possible that CRC metastasis is, at least partly, mediated through a polyclonal seeding mechanism. These findings demonstrated the rationale and feasibility for identifying and targeting primary tumor-derived metastasis-potent subclones for the prediction, prevention, and treatment of CRC metastasis.
BACKGROUND: Distant metastasis accounts for 90% of deaths from colorectal cancer (CRC). Genomic heterogeneity has been reported in various solid malignancies, but remains largely under-explored in metastatic CRC tumors, especially in primary to metastatic tumor evolution. PATIENTS AND METHODS: We conducted high-depth whole-exome sequencing in multiple regions of matched primary and metastatic CRC tumors. Using a total of 28 tumor, normal, and lymph node tissues, we analyzed inter- and intra-individual heterogeneity, inferred the tumor subclonal architectures, and depicted the subclonal evolutionary routes from primary to metastatic tumors. RESULTS: CRC has significant inter-individual but relatively limited intra-individual heterogeneity. Genomic landscapes were more similar within primary, metastatic, or lymph node tumors than across these types. Metastatic tumors exhibited less intratumor heterogeneity than primary tumors, indicating that single-region sequencing may be adequate to identify important metastasis mutations to guide treatment. Remarkably, all metastatic tumors inherited multiple genetically distinct subclones from primary tumors, supporting a possible polyclonal seeding mechanism for metastasis. Analysis of one patient with the trio samples of primary, metastatic, and lymph node tumors supported a mechanism of synchronous parallel dissemination from the primary to metastatic tumors that was not mediated through lymph nodes. CONCLUSIONS: In CRC, metastatic tumors have different but less heterogeneous genomic landscapes than primary tumors. It is possible that CRC metastasis is, at least partly, mediated through a polyclonal seeding mechanism. These findings demonstrated the rationale and feasibility for identifying and targeting primary tumor-derived metastasis-potent subclones for the prediction, prevention, and treatment of CRC metastasis.
Authors: Noemi Andor; Trevor A Graham; Marnix Jansen; Li C Xia; C Athena Aktipis; Claudia Petritsch; Hanlee P Ji; Carlo C Maley Journal: Nat Med Date: 2015-11-30 Impact factor: 53.440
Authors: Richard Kim; Michael J Schell; Jamie K Teer; Danielle M Greenawalt; Mingli Yang; Timothy J Yeatman Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240
Authors: Changhua Zhou; Ashley M Nitschke; Wei Xiong; Qiang Zhang; Yan Tang; Michael Bloch; Steven Elliott; Yun Zhu; Lindsey Bazzone; David Yu; Christopher B Weldon; Rachel Schiff; John A McLachlan; Barbara S Beckman; Thomas E Wiese; Kenneth P Nephew; Bin Shan; Matthew E Burow; Guangdi Wang Journal: Breast Cancer Res Date: 2008-12-16 Impact factor: 6.466
Authors: Jae-Hui Kim; Ji Yun Jeong; An Na Seo; Nora Jee-Young Park; Moonsik Kim; Ji Young Park Journal: In Vivo Date: 2022 Jan-Feb Impact factor: 2.155
Authors: Ha X Dang; Bradley A Krasnick; Brian S White; Julie G Grossman; Matthew S Strand; Jin Zhang; Christopher R Cabanski; Christopher A Miller; Robert S Fulton; S Peter Goedegebuure; Catrina C Fronick; Malachi Griffith; David E Larson; Brian D Goetz; Jason R Walker; William G Hawkins; Steven M Strasberg; David C Linehan; Kian H Lim; A Craig Lockhart; Elaine R Mardis; Richard K Wilson; Timothy J Ley; Christopher A Maher; Ryan C Fields Journal: Sci Adv Date: 2020-06-10 Impact factor: 14.136
Authors: Rui Luo; Weelic Chong; Qiang Wei; Zhenchao Zhang; Chun Wang; Zhong Ye; Maysa M Abu-Khalaf; Daniel P Silver; Robert T Stapp; Wei Jiang; Ronald E Myers; Bingshan Li; Massimo Cristofanilli; Hushan Yang Journal: NPJ Breast Cancer Date: 2021-06-01